JAK2 and myeloproliferative disorder: Loss of function mutations in JAK3 result in Severe Combined Immunodeficiency Disease (SCID), as do mutations in the common gamma chain receptor which recruits JAK39–11 while activating mutations in JAK2 are a frequent cause of myeloproliferative disorders such as myelofibrosis and polycythaemia12,13.